Investment Stage

Focus Areas

About Investor

Jamil Beg is Partner on the Biotech team at SV Health Investors. He is a life science investor and company builder focused on turning breakthrough science into transformational medicines, with investment experience across therapeutic areas and modalities from company creation to later clinical-stage companies. Before joining SV in 2024, he was a Partner at 5AM Ventures. His background includes more than twenty private financings, seven public offerings, three M&A transactions, six venture-backed startup operating roles, and work connected to multiple FDA-approved products.